Macrophages associated with tumors as potential targets and therapeutic intermediates

Serguei V Vinogradov, Galya Warren, Xin Wei

Research output: Contribution to journalReview article

38 Citations (Scopus)

Abstract

Tumor-associated macrophages (TAMs) form approximately 50% of tumor mass. TAMs were shown to promote tumor growth by suppressing immunocompetent cells, inducing neovascularization and supporting cancer stem cells. TAMs retain mobility in tumor mass, which can potentially be employed for better intratumoral biodistribution of nanocarriers and effective tumor growth inhibition. Due to the importance of TAMs, they are increasingly becoming principal targets of novel therapeutic approaches. In this review, we compare features of macrophages and TAMs that are essential for TAM-directed therapies, and illustrate the advantages of nanomedicine that are related to the preferential capture of nanocarriers by Mφ in the process of drug delivery. We discuss recent efforts in reprogramming or inhibiting tumor-protecting properties of TAMs, and potential strategies to increase efficacy of conventional chemotherapy by combining with macrophage-associated delivery of nanodrugs.

Original languageEnglish (US)
Pages (from-to)695-707
Number of pages13
JournalNanomedicine
Volume9
Issue number5
DOIs
StatePublished - Jan 1 2014

Fingerprint

Macrophages
tumor
Tumors
Neoplasms
cancer
drug
Therapeutics
Nanomedicine
Medical nanotechnology
chemotherapy
Chemotherapy
Neoplastic Stem Cells
Growth
Stem cells
Drug delivery
stem

Keywords

  • 'Trojan horses'
  • biodistribution of nanoparticles
  • cancer stem cell
  • eradication of cancer cells
  • macrophage
  • nanocarrier
  • phagocytosis
  • reprogramming of macrophages
  • tumor-associated macrophage
  • tumor-supporting function

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Bioengineering
  • Biomedical Engineering
  • Development
  • Materials Science(all)

Cite this

Macrophages associated with tumors as potential targets and therapeutic intermediates. / Vinogradov, Serguei V; Warren, Galya; Wei, Xin.

In: Nanomedicine, Vol. 9, No. 5, 01.01.2014, p. 695-707.

Research output: Contribution to journalReview article

Vinogradov, Serguei V ; Warren, Galya ; Wei, Xin. / Macrophages associated with tumors as potential targets and therapeutic intermediates. In: Nanomedicine. 2014 ; Vol. 9, No. 5. pp. 695-707.
@article{95830d527ea44628ac636ab84d60b119,
title = "Macrophages associated with tumors as potential targets and therapeutic intermediates",
abstract = "Tumor-associated macrophages (TAMs) form approximately 50{\%} of tumor mass. TAMs were shown to promote tumor growth by suppressing immunocompetent cells, inducing neovascularization and supporting cancer stem cells. TAMs retain mobility in tumor mass, which can potentially be employed for better intratumoral biodistribution of nanocarriers and effective tumor growth inhibition. Due to the importance of TAMs, they are increasingly becoming principal targets of novel therapeutic approaches. In this review, we compare features of macrophages and TAMs that are essential for TAM-directed therapies, and illustrate the advantages of nanomedicine that are related to the preferential capture of nanocarriers by Mφ in the process of drug delivery. We discuss recent efforts in reprogramming or inhibiting tumor-protecting properties of TAMs, and potential strategies to increase efficacy of conventional chemotherapy by combining with macrophage-associated delivery of nanodrugs.",
keywords = "'Trojan horses', biodistribution of nanoparticles, cancer stem cell, eradication of cancer cells, macrophage, nanocarrier, phagocytosis, reprogramming of macrophages, tumor-associated macrophage, tumor-supporting function",
author = "Vinogradov, {Serguei V} and Galya Warren and Xin Wei",
year = "2014",
month = "1",
day = "1",
doi = "10.2217/nnm.14.13",
language = "English (US)",
volume = "9",
pages = "695--707",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Macrophages associated with tumors as potential targets and therapeutic intermediates

AU - Vinogradov, Serguei V

AU - Warren, Galya

AU - Wei, Xin

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Tumor-associated macrophages (TAMs) form approximately 50% of tumor mass. TAMs were shown to promote tumor growth by suppressing immunocompetent cells, inducing neovascularization and supporting cancer stem cells. TAMs retain mobility in tumor mass, which can potentially be employed for better intratumoral biodistribution of nanocarriers and effective tumor growth inhibition. Due to the importance of TAMs, they are increasingly becoming principal targets of novel therapeutic approaches. In this review, we compare features of macrophages and TAMs that are essential for TAM-directed therapies, and illustrate the advantages of nanomedicine that are related to the preferential capture of nanocarriers by Mφ in the process of drug delivery. We discuss recent efforts in reprogramming or inhibiting tumor-protecting properties of TAMs, and potential strategies to increase efficacy of conventional chemotherapy by combining with macrophage-associated delivery of nanodrugs.

AB - Tumor-associated macrophages (TAMs) form approximately 50% of tumor mass. TAMs were shown to promote tumor growth by suppressing immunocompetent cells, inducing neovascularization and supporting cancer stem cells. TAMs retain mobility in tumor mass, which can potentially be employed for better intratumoral biodistribution of nanocarriers and effective tumor growth inhibition. Due to the importance of TAMs, they are increasingly becoming principal targets of novel therapeutic approaches. In this review, we compare features of macrophages and TAMs that are essential for TAM-directed therapies, and illustrate the advantages of nanomedicine that are related to the preferential capture of nanocarriers by Mφ in the process of drug delivery. We discuss recent efforts in reprogramming or inhibiting tumor-protecting properties of TAMs, and potential strategies to increase efficacy of conventional chemotherapy by combining with macrophage-associated delivery of nanodrugs.

KW - 'Trojan horses'

KW - biodistribution of nanoparticles

KW - cancer stem cell

KW - eradication of cancer cells

KW - macrophage

KW - nanocarrier

KW - phagocytosis

KW - reprogramming of macrophages

KW - tumor-associated macrophage

KW - tumor-supporting function

UR - http://www.scopus.com/inward/record.url?scp=84901048028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901048028&partnerID=8YFLogxK

U2 - 10.2217/nnm.14.13

DO - 10.2217/nnm.14.13

M3 - Review article

VL - 9

SP - 695

EP - 707

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 5

ER -